Hasil Pencarian - Xielan Zhao

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Joint status and related risk factors in patients with severe hemophilia A: a single-center cross-sectional study

    Joint status and related risk factors in patients with severe hemophilia A: a single-center cross-sectional study oleh Liang Zhao, Hongbin Yang, Yaochun Li, Zhongqing Wang, Li Zhou, Xielan Zhao, Jie Peng

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Generating Aptamers by Cell-SELEX for Applications in Molecular Medicine

    Generating Aptamers by Cell-SELEX for Applications in Molecular Medicine oleh Huixia Liu, Xielan Zhao, Weihong Tan, Jun Liu, Minyuan Peng, Jing Liu, Jun Hu, Mao Ye

    Diterbitkan 2012-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Primary breast CD20-positive extranodal NK/T cell lymphoma with stomach involvement: a case report and literature review

    Primary breast CD20-positive extranodal NK/T cell lymphoma with stomach involvement: a case report and literature review oleh Ying Zhang, Kuansong Wang, Qian Tan, Keda Yang, Dengshu Wu, Yajing Xu, Xielan Zhao, Zhiping Jiang

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    PB1929: EFFICACY AND SAFETY OF ACALABRUTINIB IN CHINESE PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: AN OPEN-LABEL, MULTICENTER PHASE 1/2 TRIAL

    PB1929: EFFICACY AND SAFETY OF ACALABRUTINIB IN CHINESE PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: AN OPEN-LABEL, MULTICENTER PHASE 1/2 TRIAL oleh Shenmiao Yang, Haiwen Huang, Keshu Zhou, Xielan Zhao, Yan-Qiu Han#, Lindong LI, Anna Butturini, Yiqiu Wang, Xiaofeng Liu, Peiqiong Lai, Jianyong LI

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Prophylactic emicizumab for hemophilia A in the Asia‐Pacific region: A randomized study (HAVEN 5)

    Prophylactic emicizumab for hemophilia A in the Asia‐Pacific region: A randomized study (HAVEN 5) oleh Renchi Yang, Shujie Wang, Xuefeng Wang, Jing Sun, Ampaiwan Chuansumrit, Jianfeng Zhou, Christophe Schmitt, Wanling Hsu, Jeffrey Xu, Lindong Li, Tiffany Chang, Xielan Zhao

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients

    Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients oleh Suwei Wang, Xiaoqing Yuan, Yazhen Liu, Kewei Zhu, Peng Chen, Han Yan, Daoyu Zhang, Xi Li, Hui Zeng, Xielan Zhao, Xiaoping Chen, Gan Zhou, Shan Cao

    Diterbitkan 2019-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A

    Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A oleh Yongqiang Zhao PhD, Yu Hu PhD, Jie Jin PhD, Xielan Zhao PhD, Xuefeng Wang PhD, Runhui Wu PhD, Depei Wu MD, Renchi Yang PhD, Feng’e Yang MD, Qun Hu PhD, Juan Wang MD, Hai Fang MD, Werner Engl PhD

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY

    P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY oleh Zhong Zheng, Huilai Zhang, Keshu Zhou, Hui Zhou, LI Zhang, Caixia LI, Min Zhou, Wenbin Qian, Zhiming LI, Qingyuan Zhang, Ying Cheng, Liu Peng, Zhenyu LI, Liping Su, Fei LI, Xiuhua Sun, Jingwen Wang, Yuhuan Gao, Xielan Zhao, Kunyan LI, Kaiyang Ding, Zunmin Zhu, Ying Wang, Hongmei Jing, Xiaohong Xu, Xin Wang, Zimin Sun, Da Gao, Wei-LI Zhao

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    P635: AN UPDATE OF SAFETY AND EFFICACY RESULTS FROM PHASE 1 STUDY OF LP-108, A NOVEL AND SELECTIVE BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMAS

    P635: AN UPDATE OF SAFETY AND EFFICACY RESULTS FROM PHASE 1 STUDY OF LP-108, A NOVEL AND SELECTIVE BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPH... oleh Wei Xu, Ru Feng, LI Wang, Huayuan Zhu, Keshu Zhou, Xiaorui Fu, Hongmei Jing, Yuqin Song, Junyuan Qi, Guohui Cui, Fei LI, Shaoyuan Wang, Hui Zhou, Wenbin Qian, Qingqing Cai, Xielan Zhao, Xutao Guo, Xiaolei Wei, Ningjing Lin, Zhongyuan Xu, Zheng Wang, Xiang Xiao, Jiale Dong, Yejiang Lou, Yue Shen, Yi Chen, Yu Chen, Fenlai Tan, Stephen Anthony, Jianyong LI

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma

    A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma oleh Yuankai Shi, Yongping Song, Yan Qin, Qingyuan Zhang, Xiaohong Han, Xiaonan Hong, Dong Wang, Wei Li, Yang Zhang, Jifeng Feng, Jianmin Yang, Huilai Zhang, Chuan Jin, Yu Yang, Jianda Hu, Zhao Wang, Zhengming Jin, Hang Su, Huaqing Wang, Haiyan Yang, Weijun Fu, Mingzhi Zhang, Xiaohong Zhang, Yun Chen, Xiaoyan Ke, Li Liu, Ding Yu, Guo’an Chen, Xiuli Wang, Jie Jin, Tao Sun, Xin Du, Ying Cheng, Pingyong Yi, Xielan Zhao, Chaoming Ma, Jiancheng Cheng, Katherine Chai, Alvin Luk, Eugene Liu, Xin Zhang

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: